Zealand Pharma — Marts 2025
-
Hvor meget skal aktiekursen falde, før Adam og resten af ledelsen indser, at markedet ikke deler deres vision om at blive den nye Genmab? Tror de virkelig, at investorerne vil blive ved med at finansiere drømmen gennem nye aktieemissioner? Kursen er nu markant lavere end før udmeldingen af fase 1-resultaterne for Petrelintid.
-
Selv på dette niveau reducerer shorterne ikke deres positioner, tværtimod øger de dem: https://www.zirium.dk/short-watch-details?code=DK0060257814
-
Godmorgen
-
Godmorgen
-
Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity
-
Nordnet
Tag kontrol over dine opsparinger. Invester i aktier, midler eller spar til din pension uden unødvendige gebyrer. Åbn konto i dag!
Nordnet (www.nordnet.dk)
-
En spændende dag forude.
-
Det må man sige
-
Endelig lidt medgang
Nogle bud på hvad den kan give i kursstigning? -
Zeal er jo stort set halveret siden toppen i 962 d. 20/8 2024….der må være masser af luft til en pæn stigning
-
Zealand Pharma: Vauw for en gigantaftale https://proinvestor.com/boards/125125
-
Zealand Pharma finder schweizisk partner til sin kronjuvel https://proinvestor.com/investornyt/1290066/zealand-pharma-finder-schweizisk-partner-til-sin-kronjuvel
-
Super for Zealand Pharma men timingen kunne have været bedre.
-
Jeg tør godt at lægge hovedet på blokken. 50 pct kursstigning vil være fair. Men markedet bestemmer.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind